De Heer J, Rasmussen C, Coy DH, Holst JJ
The FDAs Position During And After The National Semaglutide Shortage During the national drug shortages of GLP-1 medications, the FDA has permitted licensed pharmacies to compound semaglutide to meet patient needs, provided they follow the rules outlined in the Federal Food, Drug, and Cosmetic Act
Ensure all samples return negative results for coliform bacteria before considering the line safe for service
If covered but with high cost-sharing, manufacturer programs may help Novo Nordisk offers copay cards for Wegovy and Ozempic (up to $500/month off) Eli Lilly offers copay cards for Zepbound and Mounjaro (up to $550/month off) Copay cards typically don't work with self-funded employer plans due to copay accumulator programs The written coverage determination (step 4) is the most reliable
A single week without progress, disrupted sleep, hormonal fluctuations around your cycle, or a period of higher stress can all produce a temporary stall that resolves without any medication change